136 related articles for article (PubMed ID: 38413705)
1. Exploration and machine learning model development for T2 NSCLC with bronchus infiltration and obstructive pneumonia/atelectasis.
Jin X; Pan Y; Zhai C; Shen H; You L; Pan H
Sci Rep; 2024 Feb; 14(1):4793. PubMed ID: 38413705
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Chest; 2008 Mar; 133(3):662-9. PubMed ID: 17925418
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the non-small cell lung cancer patients with bronchus involvements: A population-based study.
Wang G; Ye YQ; Xie BL; Lai XM; Zhong SP
Clin Respir J; 2023 Sep; 17(9):941-950. PubMed ID: 37545476
[TBL] [Abstract][Full Text] [Related]
4. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
5. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
6. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
[TBL] [Abstract][Full Text] [Related]
7. Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database.
Komiya T; Chaaya G; Powell E
Radiother Oncol; 2019 Feb; 131():75-80. PubMed ID: 30773190
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study.
Wang Q; Wang S; Sun Z; Cao M; Zhao X
BMC Cancer; 2022 Jul; 22(1):801. PubMed ID: 35858848
[TBL] [Abstract][Full Text] [Related]
9. Prognosis and staging of superficial endobronchial lung cancer: the impact of invasion depth, tumor diameter, and coexistent pneumonitis or atelectasis.
Chen C; Zheng H; Gao W; Zhou Y; Jiang S; Suen HC
Chin Med J (Engl); 2010 Jun; 123(12):1505-9. PubMed ID: 20819501
[TBL] [Abstract][Full Text] [Related]
10. Reconsidering the American Joint Committee on Cancer Eighth Edition TNM Staging Manual Classifications for T2b and T3 NSCLC.
Kumar A; Kumar S; Gilja S; Potter AL; Raman V; Muniappan A; Liou DZ; Jeffrey Yang CF
J Thorac Oncol; 2021 Oct; 16(10):1672-1683. PubMed ID: 34242788
[TBL] [Abstract][Full Text] [Related]
11. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
[TBL] [Abstract][Full Text] [Related]
12. Preoperative radiation may improve the outcomes of resectable IIIA/N2 non-small-cell lung cancer patients: A propensity score matching-based analysis from surveillance, epidemiology, and end results database.
Chen D; Wang H; Song X; Yue J; Yu J
Cancer Med; 2018 Sep; 7(9):4354-4360. PubMed ID: 30058192
[TBL] [Abstract][Full Text] [Related]
13. Marital status independently predicts non-small cell lung cancer survival: a propensity-adjusted SEER database analysis.
Chen Z; Yin K; Zheng D; Gu J; Luo J; Wang S; Chen H
J Cancer Res Clin Oncol; 2020 Jan; 146(1):67-74. PubMed ID: 31786738
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of visceral pleural invasion in the stage pT
Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
[TBL] [Abstract][Full Text] [Related]
15. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
16. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
17. A Nomogram Based on Atelectasis/Obstructive Pneumonitis Could Predict the Metastasis of Lymph Nodes and Postoperative Survival of Pathological N0 Classification in Non-small Cell Lung Cancer Patients.
Liu YH; Wu LL; Qian JY; Li ZX; Shi MX; Wang ZR; Xie LY; Liu Y; Xie D; Cao WJ
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830869
[TBL] [Abstract][Full Text] [Related]
18. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
[TBL] [Abstract][Full Text] [Related]
19. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
[TBL] [Abstract][Full Text] [Related]
20. Risk and prognostic factors of brain metastasis in lung cancer patients: a Surveillance, Epidemiology, and End Results population‑based cohort study.
Hao Y; Li G
Eur J Cancer Prev; 2023 Sep; 32(5):498-511. PubMed ID: 36804864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
